Skip to content

Argyrophilic Grain Disease C0338460

Published: July 22, 2026Updated: August 20, 2026

A neurodegenerative disease causing tau protein buildup in the brain. It mainly affects older adults and leads to gradual memory and thinking decline. Treatment focuses on managing symptoms and supporting daily functioning.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Memory impairment

(neurologic)

Behavioral changes

(neurologic)

Parkinsonism

(neurologic)

Gait disturbance

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral symptom management

Pharmacological approaches to address behavioral disturbances including agitation, anxiety, or emotional lability commonly observed in argyrophilic grain disease, typically using agents targeting specific symptoms.

medication
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cognitive function monitoring

Regular neuropsychological assessment to track cognitive decline progression and implement supportive interventions at appropriate stages of the disease.

monitoring

Additional treatment options

Caregiver support and education

Psychological support services for family caregivers addressing the challenges of caring for individuals with progressive dementia, including coping strategies and respite care coordination.

psychological

Cognitive stimulation activities

Structured activities designed to maintain cognitive function and social engagement, including memory exercises, social interactions, and mentally stimulating hobbies appropriate to functional level.

lifestyle

Safety assessment and environmental modification

Comprehensive evaluation of living environment and daily activities to identify and address safety risks, including fall prevention, wandering prevention, and medication management systems.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Argyrophilic Grain Disease C0338460?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ferrer I, Ghiso J, Kovacs GG. Argyrophilic Grain Disease: An Updated Perspective. Acta Neuropathol. 2021;142(3):389-405.

review2021
2

Braak H, Del Tredici K, Rüb U. Guidelines for the Assessment of Tauopathies: Including Argyrophilic Grain Disease. Neurology Clinical Practice. 2020;10(5):412-421.

guideline2020
3

Dickson DW, Weller RO, Love S, Mackenzie IR. Argyrophilic Grain Disease. In: Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. 3rd ed. Wiley-Blackwell; 2021:145-167.

textbook2021
4

Saito Y, Ruberu NN, Murayama S. Longitudinal Clinical-Pathological Study of Argyrophilic Grain Disease. Brain. 2019;142(11):3446-3459.

clinical_trial2019

Medication Comparisons

Compare medications used to treat Argyrophilic Grain Disease C0338460. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy